Form 4 for EW Edwards Lifesciences
Accepted 2026-07-10 17:11:14 ET · period of report 2026-07-09 · accession 0001225208-26-006578 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-07-10 17:11 | 2026-07-09 | EW | Mistras Theodora | CFO, CVP | A - Grant | $0.00 | +99.9K | 99.9K | New | $0 |
| DM | 2026-07-10 17:11 | 2026-07-09 | EW | Mistras Theodora | CFO, CVP | A - Grant | $0.00 | +74.1K | 12.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-09 | A | A | 87,595 | $0.00 | 87,595 | D | — | — | (F1) These restricted stock units were granted on July 9, 2026, under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest as follows: 43.75% on the first anniversary of May 29, 2026 (the "Start Date"), 50% on the second anniversary of the Start Date, and the remaining 6.25% on the third anniversary of the Start Date. |
| 2 | Common | Common Stock | 2026-07-09 | A | A | 12,325 | $0.00 | 99,920 | D | — | — | (F2) These restricted stock units were granted on July 9, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2026-07-09 | A | A | 61,800 | $0.00 | 61,800 | D | $91.33 · 2027-07-09 to 2033-07-08 | 61,800 Common Stock | (F3) These options were granted on July 9, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. |
| 4 | Derivative | Performance Rights | 2026-07-09 | A | A | 12,325 | $0.00 | 12,325 | D | — · 2029-07-09 to — | 12,325 Common Stock | (F4) Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on July 9, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards. (F4) Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on July 9, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards. |